Aurobindo Ebitda from 2010 to 2024
| AUROPHARMA | 1,238 14.45 1.18% |
EBITDA | First Reported 2011-12-31 | Previous Quarter 16.2 B | Current Value 17 B | Quarterly Volatility 4.3 B |
Check Aurobindo Pharma financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Aurobindo Pharma's main balance sheet or income statement drivers, such as Depreciation And Amortization of 15.7 B, Interest Expense of 3 B or Selling General Administrative of 8.6 B, as well as many indicators such as . Aurobindo financial statements analysis is a perfect complement when working with Aurobindo Pharma Valuation or Volatility modules.
Aurobindo | Ebitda |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Aurobindo Stock
Aurobindo Pharma financial ratios help investors to determine whether Aurobindo Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Aurobindo with respect to the benefits of owning Aurobindo Pharma security.